← Back to headlines
BioArctic Reports Q2 2026 Results with Rising Leqembi Royalties
The biotech firm's second-quarter financials show expanding partnerships and growing royalty income from Leqembi offsetting near-term operational losses.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
